Imunoterapia pode aumentar sobrevida em casos de linfoma de Hodgkin

Imunoterapia pode aumentar sobrevida em casos avançados de linfoma de Hodgkin

[{"selector":"#anim-8642675f-3fd0-4240-9d62-cfbbfbd3316a","keyframes":{"opacity":[0,1]},"delay":0,"duration":1000,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-776f665a-cd79-4eab-8828-16c36880f835","keyframes":{"opacity":[0,1]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] [{"selector":"#anim-d05a9c47-03fd-4ade-b536-97e0f5b0ed8a","keyframes":{"transform":["scale(0.3333333333333333)","scale(1)"]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}] [{"selector":"#anim-2ec00b0e-8fbe-4fc4-8bf9-8e51e7fa6492","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] Freepik

[{"selector":"#anim-ff3479e3-08bd-4690-b9d2-c576c01ee8af","keyframes":{"opacity":[0,1]},"delay":0,"duration":1500,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-f375bc36-4ee4-47cc-a936-36dd8f6da37c","keyframes":{"opacity":[0,1]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] [{"selector":"#anim-b5e8bcc7-246a-4447-a0ed-b38ad39f2822","keyframes":{"transform":["scale(0.3333333333333333)","scale(1)"]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}] [{"selector":"#anim-1c8e252b-977c-479c-b44e-414ef87e1bdc","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-22ab2a0b-851f-47b4-b702-c7180099cd34 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(7.812499744007886%, 0, 0)","translate3d(0%, 0, 0)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] Um novo ensaio clínico mostrou que a combinação de nivolumabe com quimioterapias aumentou a taxa de sobrevivência em pacientes com linfoma de Hodgkin em estágio avançado Freepik

[{"selector":"#anim-91df6164-2224-484c-a97d-fe70d417065d","keyframes":{"opacity":[0,1]},"delay":0,"duration":1500,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-027a4842-e41b-4c3a-8c23-75bbc0861bf0","keyframes":{"opacity":[0,1]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] [{"selector":"#anim-ae417eb3-99a6-44c2-9eab-7f7de5170dd3","keyframes":{"transform":["scale(0.3333333333333333)","scale(1)"]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}] [{"selector":"#anim-5e15a052-b9b7-45c7-ac64-9590df167d33","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] A taxa de sobrevivência livre de progressão em dois anos foi de 92% no grupo que recebeu nivolumabe, contra 83% no grupo de tratamento padrão Freepik

[{"selector":"#anim-64318dce-367a-4834-bfec-7e0d1c2ec95c","keyframes":{"opacity":[0,1]},"delay":0,"duration":1500,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-723f82b1-5139-4214-8feb-16ce2903f0e1","keyframes":{"opacity":[0,1]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] [{"selector":"#anim-c5e26dd5-6fb7-4764-8b78-ed3dbcf81a1f","keyframes":{"transform":["scale(0.3333333333333333)","scale(1)"]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}] [{"selector":"#anim-d726157f-8e15-46f9-a9a7-701d1083534e","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-227160cd-3958-437b-9b4c-382d82c4d2b1 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(-29.912499878109827%, 0, 0)","translate3d(0%, 0, 0)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] O estudo incluiu cerca de 1.000 pacientes com 12 anos ou mais, e demonstrou que a combinação reduziu a necessidade de radioterapia Freepik

[{"selector":"#anim-dbad7262-bbd1-4577-919c-26244f341cf3","keyframes":{"opacity":[0,1]},"delay":0,"duration":1500,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-ccc23ebd-b145-4352-a421-8481799f8435","keyframes":{"opacity":[0,1]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] [{"selector":"#anim-5d949395-e3ba-4b63-bd5c-37e7e1e678a1","keyframes":{"transform":["scale(0.3333333333333333)","scale(1)"]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}] [{"selector":"#anim-3477ae99-f175-46a1-be3d-8ce41e443c01","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] O principal efeito colateral do nivolumabe foi a neutropenia, mas foi bem controlado em muitos casos Freepik

[{"selector":"#anim-ed495a22-725d-4cb2-84e0-b090ace81b96","keyframes":{"opacity":[0,1]},"delay":0,"duration":1500,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-7acc58f2-372b-42c8-b447-c5c387949865","keyframes":{"opacity":[0,1]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] [{"selector":"#anim-19ea82d4-591a-40bb-be92-57407686554c","keyframes":{"transform":["scale(0.3333333333333333)","scale(1)"]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}] [{"selector":"#anim-234644ec-53f9-4e3d-b7c0-72ce07fa1ead","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-142e87e2-31f6-4385-8459-c076759afc59 [data-leaf-element=\"true\"]","keyframes":{"transform":["translate3d(-24.652777664003498%, 0, 0)","translate3d(0%, 0, 0)"]},"delay":0,"duration":2000,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] Menos pacientes no grupo de nivolumabe interromperam o tratamento precocemente em comparação com o grupo de tratamento padrão Freepik

[{"selector":"#anim-5aada0d5-9588-4d1f-bbde-a48ca27875be","keyframes":{"opacity":[0,1]},"delay":0,"duration":1500,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-38fe3d4e-e777-4580-ad4f-33db017c4b13","keyframes":{"opacity":[0,1]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] [{"selector":"#anim-563581b8-ba61-4de2-8116-8fd3a6a1d296","keyframes":{"transform":["scale(0.3333333333333333)","scale(1)"]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}] [{"selector":"#anim-8c0f68fe-a816-4a0f-98b7-971c42ff98a6","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] Pesquisadores esperam que a FDA aprove o nivolumabe como tratamento padrão para linfoma de Hodgkin em estágio avançado Freepik

CNNBRASIL.COM.BR

[{"selector":"#anim-19b6dc13-c2b6-45bf-94f2-75b26ab67cb7","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-04598115-fd49-4901-b75d-424061a09aad","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-03c3e069-a9d0-4115-b777-1125102429d7","keyframes":{"opacity":[0,1]},"delay":0,"duration":1000,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-c0037cde-e636-4097-9b7b-9efc72246ab7","keyframes":{"transform":["translate3d(0px, 2132.63615%, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":1000,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-7999d30e-e70c-4900-9b53-7b31851d4f41","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-289ad3d7-bf34-4ec3-b764-0cecb9a53e3f","keyframes":{"transform":["translate3d(-117.84387%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-cb8d6c7c-dac4-4ffa-9051-7a428c8f0f7f","keyframes":{"opacity":[0,1]},"delay":0,"duration":1000,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-e9f3f76e-c180-41b9-b1e5-c43c762a2d2b","keyframes":{"transform":["translate3d(0px, 1223.93157%, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":1000,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] Freepik leia mais em